Research News

A new oral pill for geographic atrophy is being tested in an early-stage clinical trial.

Donald Weaver’s $1 million BrightFocus Centennial grant helped lead to his new exploration of Alzheimer’s roots, which he and colleagues have proposed may lie with an out-of-control autoimmune reaction. 

Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.

An interdisciplinary team of Harvard scientists has successfully reprogrammed cells in mice to reverse vision loss from glaucoma, as well as normal (not disease-related) vision loss associated with aging in mouse models.

Recent BrightFocus grantee Sheldon Rowan tells how the Mediterranean diet, the microbiome, and other factors come together in a solid defense against AMD.

Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.

The research and discoveries of clinician-scientist Joel S. Schuman, MD, are having a big impact on vision diseases, including glaucoma. Early support from BrightFocus had a big impact on his career.